FDA Drug Recalls

Recalls / Class III

Class IIID-1240-2014

Product

Nicotine polacrilex lozenge, 4 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. Labeled a. Nicorette, Distributed By: GlaxoSmithKline Consumer Healthcare, L.P., Moon Township, PA 15108. Made in Switzerland. 72 Count NDC: 0135-0511-01,108 Count NDC: 0135-0515-03, b. Nicotine Lozenge Kroger, Lozenge Kroger, Distributed by: The Kroger Company, Cincinnati, Ohio 45202, 72 Count NDC:30142-862-01 and c. Nicotine Walgreens, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015. 72 Count NDC: 0363-0209-01, 108 Count NDC: 0363-0209-07.

Brand name
Nicorette
Generic name
Nicotine Polacrilex
Active ingredient
Nicotine
Route
Oral
NDCs
0135-0510, 0135-0511
FDA application
NDA021330
Affected lot / code info
Labeled A) 72 Ct Vial: Lot # 13434 (exp 4/14), 13546 (exp 5/14), 13907 (exp 11/14), 14020 (exp 1/15), 14107 (exp 3/15), 14183 (exp 4/15), 14273 (exp 7/15), 14335 (exp 8/15), & 14421 (exp 9/15), 12F27N (exp 4/14), 12K01N (exp 5/14), 13A25N (exp 11/14) & 13C18N (exp 1/15); 108 Ct Vial, Lot # 13383 (exp 4/14), 13626 (exp 5/14), 13725 (exp 10/14), 13861 (exp 12/14), 13980 (exp 1/15), 13982 (exp 1/15), 14091 (exp 4/15), 14153 (exp 5/15), 14227 (exp 7/15), 14262 (exp 7/15), 14318 (exp 8/15), 14371 (exp 8/15) & 14458 (exp 10/15). Labeled B) 72 Ct Vial; Lot # 13924 (exp 12/14),13975 (exp 12/14),14434 (exp 10/15). Labeled C) 72 Ct Vials, Lot #13614 (exp 7/14), 13790 (exp 10/14), 13889 (exp 11/14) & 14018 (exp 12/14), Lot # 13683 (4/17) & 13862 (11/14), 108 Ct Vial, Lot #13726 (exp 10/14) & 13779 (exp 11/14).

Why it was recalled

Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Recalling firm

Firm
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
Manufacturer
Haleon US Holdings LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
65 Windham Blvd, N/A, Aiken, South Carolina 29805-9384

Distribution

Quantity
603,696 72 Ct Vials, 191,040 108 Ct Vials
Distribution pattern
U.S. Nationwide

Timeline

Recall initiated
2014-02-20
FDA classified
2014-04-18
Posted by FDA
2014-04-30
Terminated
2017-01-20
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1240-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.